acarix Corporate Action, IR, Issuance, MAR, News, Regulatory, Shares, Swedish November 18, 2024 18 Oct 2023 Acarix offentliggör preliminärt utfall i företrädesemission EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HON... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 12 Oct 2023 Invitation to digital live presentation with Acarix Acarix, a leader in acoustic and AI-based cardiac diagnostics, invites to a digital investor presentation on Friday October 13, 2023 at... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 12 Oct 2023 Inbjudan till digital live-presentation med Acarix Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, bjuder in till en digital investerarpresentation fredagen den 13 okt... Continue reading
acarix Corporate Action, English, IR, Listing Regulation, News, Prospectus, Regulatory November 18, 2024 03 Oct 2023 Acarix publishes prospectus in connection with the company’s fully guaranteed rights issue NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ... Continue reading
acarix Corporate Action, IR, Listing Regulation, News, Prospectus, Regulatory, Swedish November 18, 2024 03 Oct 2023 Acarix offentliggör prospekt i samband med bolagets fullt garanterade företrädesemission EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HON... Continue reading
acarix Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory November 18, 2024 02 Oct 2023 Acarix appoints industry veteran Fred Colen as acting CEO during temporary medical leave of CEO Helen Ljungdahl Round Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces that CEO Helen Ljungdahl Round will be taking a temporary medi... Continue reading
acarix Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish November 18, 2024 02 Oct 2023 Acarix utser industriledaren Fred Colen som tillförordnad VD medan VD Helen Ljungdahl Round tillfälligt sjukskrivs Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag att VD Helen Ljungdahl Round sjukskrivits för beh... Continue reading
acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM November 18, 2024 28 Sep 2023 Announcement from Acarix’s extra general meeting The extra general meeting of Acarix AB ("Acarix" or the "Company") was held today on 28 September 2023 and the following resolution was... Continue reading
acarix Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish November 18, 2024 28 Sep 2023 Kommuniké från extra bolagsstämma i Acarix Extra bolagsstämma i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 28 september 2023 varvid aktieägarna fattade f&... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 27 Sep 2023 Acarix expands use of CADScor System into Osteopathic Medicine Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces expanded utilization of the CADScor® System into the... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 27 Sep 2023 Acarix utökar användningen av CADScor System inom osteopatisk medicin Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag den första affären inom osteopatisk medicin ... Continue reading
acarix Corporate Action, IR, Listing Regulation, News, Other, Regulatory, Swedish November 18, 2024 14 Sep 2023 Acarix byter Certified Adviser till Penser Bank AB Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag att man byter Certified Adviser.Acarix AB har ing&arin... Continue reading